Fang Chen
MBBS PhD
Clinical Research Fellow
Fang Chen joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2006 to further develop her interest in clinical research with randomised clinical trials. She has been working on large randomised clinical trials including ORION-4, REVEAL, THRIVE, and ASCEND studies run by CTSU.
Fang has special interests in clinical trial methodology, quality of trial conduct, and outcome event adjudication. She has also acquired considerable experience in safety monitoring in drug trials and provides clinical support to research staff in local sites and regional centres in the international multi-centre trials.
Fang Chen qualified in medicine in West China University of Medical Sciences in 1986, trained in general medicine and cardiology, and practised as an associated consultant cardiologist in China, before she came to UK in 2002, and had further clinical training in interventional cardiology in London, supported by Schevening/RCP Scholarship. She also obtained a PhD degree in cardiology in Peking Medical University in 1994.
Recent publications
Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States.
Journal article
Lui JNM. et al, (2023), J Am Heart Assoc, 12
zithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group ., (2021), Lancet, 397, 605 - 612
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.
Journal article
Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342
Cancer incidence in relation to body fatness among 0.5 million men and women: Findings from the China Kadoorie Biobank.
Journal article
Wang L. et al, (2020), Int J Cancer, 146, 987 - 998
Investigating modifications to participant information materials to improve recruitment into a large randomized trial.
Journal article
HPS2-THRIVE Collaborative Group . et al, (2019), Trials, 20

